Head Office +91 8729085230

Guru Angad Nagar,
New Delhi 110092

09.00 to 18.00 Monday to Saturday

Market Overview:

Global Cell Culture Protein Surface Coatings Market is expected to offer $ opportunity of USD 1,679.30 million during the forecast period i.e. 2021-2031. 

Global Cell Culture Protein Surface Coating Market size is expected to reach USD 2,255.6 million by the end of 2031, growing at a CAGR of 14.53% over the forecast period, i.e., 2022 – 2031. When COVID-19 first appeared, a lot of biotech and pharmaceutical companies, governments from different nations, and research institutions began to concentrate on the creation of efficient vaccines and novel treatments to treat the problem. The creation of new vaccines for the treatment of COVID-19 was facilitated by cell culture.

  • According to the report distributed by the Diary of Clinical Virology in July 2022, there was a huge positive connection between the likelihood of disengaging SARS-CoV-2 in culture, less long stretches of side effects, and a lower RT-PCR cycle edge esteem. Consequently the cell culture was utilized during Coronavirus for legitimate conclusion and was supposed to develop the cell culture protein surface coatings market. As viral examinations are as yet progressing, having a critical effect in the approaching future is normal.

Global Market Size, Forecast, and Trend Over Forecast Period, 2021 - 2031

Base Year2021
Forecast Year2022-2031
CAGR14.53%
Base Year Market Size (2021)USD 576.3 Million
Forecast Year Market Size (2031)USD 2,255.6 Million

Market Dynamics:

  • Drivers: The major factors, such as increasing stem cell research activities, increasing demand for protein therapeutics and targeted therapy, and growing preference for 3D cell cultures over 2D cell cultures, are driving the growth of the market over the forecast period. The optimization of the cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components to improve the proliferation and adhesion of the cells in-vitro. Increasing stem cell research activities are expected to have a positive impact on the growth of the market.

For instance, in June 2022, the Harvard Stem Cell Institute (HSCI) invited applications for seed grant funding for its 2022 cycle. The program's objective is to offer financial support for creative initiatives in the field of stem cell and regenerative biology to accelerate the development of new stem cell-based therapies or cures. As per the same above-mentioned source, the amounted award is USD 100,000 per project per year for up to two years. Thus the funding for the research activities increases the stem cell research activities that may drive the growth of the market over the forecast period.

  • Challenges: However, the high cost of cell culture protein surface coatings products and restrictions against the use of animal-source protein coating material may impede the growth of the market.

Technological Advancements:

Microwell plates are also known as microplates or microtiter plates, or multiwells. The microplate has become a standard tool in analytical research and clinical diagnostic testing laboratories. Depending on the cell type, passage, origin, and makeup of the cell culture media, cells in culture adhere to the culture plates in various ways, even when they are grown on plastic made specifically for cell culture. 

  • The new advancements and approvals, and launches among the microwell plates drive the market growth over the study period. For instance, in April 2022, the Porvair Sciences Sero Krystal PDL family of coated microplates sets a new standard for repeatable cell culture, even with difficult cell types.
  • The advanced microplate readers in the market increase the usage of microplates in biotechnology that, drive the market. For instance, in April 2022, Molecular Devices LLC launched its SpectraMax mini multi-mode microplate reader, a compact and economical solution designed to save researchers benchtop space and budget. Similarly, in February 2022, BMG LABTECH launched the VANTAstar microplate reader, further expanding its range of high-quality, made-in-Germany instruments. VANTAstar is a compact multi-mode microplate reader and is equipped with three features that enable an effortless detection setup and improve data quality. 

Hence, the above advancements and launches are expected to have a significant impact on the market through the segment.

Regional Market Overview:

North America Estimated to Hold the Largest Share in the Market: North America is well known for its cell culture laboratories and funding for research in the healthcare domain. And it is expected to dominate the market over the forecast period. Each year in the United States, the National Institutes of Health funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers.

  • The American Cancer Society predicts that in 2022, there will be an estimated 1,918,030 new cases of cancer in the United States. The rise in cancer cases increases the demand for targeted therapies which involve cell cultures and hence are expected to have a significant impact on the market over the forecast period. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. Such factors boost the importance of cell culture activities.
  • Furthermore, the expansion of the major players in the market also has a significant impact on the market. For instance, in July 2021, Abcam, a global innovator in life sciences reagents and tools, opened a major new site in Waltham, Massachusetts, United States. The new facility is a central component of Abcam’s growth in the United States, reinforcing its commitment to support the research and biopharma sector.

Asia-Pacific market is expected to grow at a significant growth rate over the forecast period. Countries such as China, India, Japan and South Korean market lucrative markets in the region, offer numerous opportunities for the market players owing to the large number of R&D activities. Growing collaboration and funding from institution and Government are major factors expected to boost the market growth.

 

Market Segmentation:

Our in-depth analysis of the Global Cell Culture Protein Surface Coating Market includes the following segments:

Global Cell Culture Protein Surface Coating Market
Base Year:2021Forecast Period:2022-2031
Historical Data:2021Market Size in 2021:USD 576.3 Million
Forecast Period 2022-31 CAGR:14.53%Market Size in 2031:USD 2,255.6 Million
Segments Covered:By Protein Source

 

  • Animal-derived Protein
    • Gelatin
    • Others
  • Human-derived Protein
    • Collagen
    • Osteopontin
    • Others
  • Synthetic Protein
    • Poly-D-Lysin
    • Others
  • Plant-derived Protein
    • Albumin
    • Others
By Type
  • Self-coating
  • Pre-coating
    • Multiwall/microwell plates
    • Petri dishes
    • Flasks
    • Slides
    • Coverslip
By Application
  • Scientific Research
  • Industrial Production
By End User
  • Biotechnology Companies 
  • Pharmaceutical companies
  • Others
By Region
  • North America (U.S., Canada)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Saudi Arabia, Israel, UAE, South Africa, Rest of MEA)
  • South America (Brazil, Mexico, Argentina, Rest of South America)
Key Market Drivers:
  • Increasing focus on stem cell research
  • Rising investment in R&D
Key Market Restraints:
  •  Dearth of skilled professionals
Key Trends:
  • Technological innovation and new product launches
Companies Covered in the Report:
  • Bio Lamina AB
  • Merck milliopore
  • Perkin Elmer
  • Thermo Fisher Scientific, Inc.
  • Corning Incorporated
  • BD Bioscience
  • Abcam plc.
  • BioLamina AB
  • ScienCell Research Laboratories, Inc.
  • DevovoMATRIX GmbH
  • Sumitomo Bakelite Co. Ltd.
  • Fujifilm Wako Pure Chemical Co. Ltd.
  • Other Major Players

Recent Developments in the Market:

  • April 2022: Molecular Devices LLC has been continuing its investment since April 2021 in Organoid Innovation Center, adding cell engineering capabilities to an automated 3D cell culture platform. 
  • December 2021: DenovoMATRIX launched its new product, isoMATRIX, a high-yield MSC isolation technology for cell and gene therapy. It has the efficiency to get nearly 35% more stem cells with better quality and faster growth.